Latest news from Cochrane
New evidence questions the benefit of calcium supplements in pregnancy for preventing pre-eclampsia
3 Diciembre 2025
An updated Cochrane review has found that calcium supplementation has no effect on pre-eclampsia, challenging long-held assumptions about the role of calcium in preventing hypertensive disorders in pregnancy.
New research confirms HPV vaccination prevents cervical cancer
24 Noviembre 2025
Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus.
What do we know about the HPV vaccine?
24 Noviembre 2025
Learn about HPV as we answer common questions and explore how vaccination can protect children.
How can public health professionals overcome vaccine hesitation?
17 Noviembre 2025
Vaccination against human papillomavirus (HPV) is one of the most effective tools for preventing cervical cancer in women and other HPV-associated diseases in people of all genders. Yet many people worldwide remain reluctant to take the vaccine.
Global evidence highlights social roots of HPV vaccine hesitancy
17 Noviembre 2025
Decisions about the HPV vaccine among adolescents and their families are influenced by a web of social, cultural and trust-related factors, beyond simple awareness or access
Common gout drug may reduce risk of heart attack and stroke
12 Noviembre 2025
A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review.
Setting the standards for responsible AI use in evidence synthesis
11 Noviembre 2025
Cochrane, the Campbell Collaboration, JBI, and the Collaboration for Environmental Evidence have published a joint position statement on the responsible use of artificial intelligence (AI) in evidence synthesis.
GLP-1 drugs effective for weight loss, but more independent studies needed
30 Octubre 2025
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions.
What is Cochrane doing to strengthen research integrity?
29 Octubre 2025
We continue to lead the field in trustworthiness and transparency by evolving our practices to address the most pressing challenges in research integrity and publishing ethics, and to respond to rapid advances in technology. Here is a wrap up of recent developments in these areas.
Strong evidence supports skin-to-skin contact after birth as standard care
22 Octubre 2025
Immediate skin-to-skin contact between newborns and their mothers offers a better start in life, improving a number of key health metrics, according to a newly-updated Cochrane review.
Our newsletters
Get regular news about different areas of our work in your inbox. Sign up for a Cochrane account and opt into newsletters in the 'Communications' tab to subscribe.
- Patient and Public Network newsletter: monthly digest for patients and members of the public about health evidence, and helping to create it
- Early Career Professionals Network newsletter: regular resources, training, events, opportunities, features and blogs relevant to Early Career Researchers
- Author Digest: monthly updates and tips on writing systematic reviews
- Cochrane Evidence Synthesis and Methods journal: sign up for alerts on our publisher's website
- Cochrane Library newsletter: updates on new Cochrane Library features, enhancements and the latest evidence. Sign up on our publisher's website.
Media enquiries
Please see our Press office page.
